12.01.09
Israel-based Algatechnologies has received approval from FDA for the use of 12 new structural health claims filed for its AstaPure natural astaxanthin in the U.S. market. Among the health claims approved for AstaPure are claims supporting cardiovascular health, neurological health and the advantage of AstaPure in maintaining a normal oxidant/antioxidant balance. Algatechnologies produces natural astaxanthin from Haematococcus pluvialis microalgae.
